Economic evaluation of evolocumab in uncontrolled patients with high-risk cardiovascular disease affected by primary hypercholesterolemia and mixed dyslipidemia.
| Autor: | Carlos-Rivera, Fernando1 fernando.carlos@ahs-mex.com, Antonio Guzmán-Caniupan, Jorge2, Gabriel Hernández-Garduño, Adolfo3, Alva-Esqueda, Mónica, Miguel Camacho-Cordero, Luis1, Aubry-de Maraumont, Therese2 |
|---|---|
| Zdroj: | Cardiovascular & Metabolic Science. 2022, Vol. 33 Issue 2, p52-63. 12p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|